FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (CIPLA USA INC.,)

View source ↗

Summary

FDA approved a supplemental application for Bupropion hydrochloride submitted by Cipla USA Inc., reflecting a regulatory action on an existing product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)